Apollomics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
APLM Nasdaq 2834 www.apollomicsinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apollomics, Inc.

Apollomics Reports First Half 2025 Financial Results - Dec 22nd, 2025 2:05 pm
Apollomics Announces Settlement of Cayman Litigation - Nov 19th, 2025 3:38 pm
Apollomics Announces Changes to its Board of Directors and Composition of Committees - Nov 17th, 2025 9:00 pm
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation - Oct 15th, 2025 12:36 pm
Apollomics, Inc. Company Operational Continuity Update - Oct 13th, 2025 7:22 pm
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress - Apr 3rd, 2025 2:05 pm
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib - Mar 31st, 2025 6:00 am